Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Daily News

Immediate Angiography in OHCA Without STEMI Could Harm: TOMAHAWK and COACT

Caitlin E. Cox

December 27, 2024

News Daily News

Top Coronary Artery Disease News in 2024

Michael O'Riordan

December 26, 2024

News Conference News TCT 2024

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

Todd Neale

October 30, 2024

News Conference News TCT 2024

DCB Outdo Noncompliant Balloons in Simple Bifurcation Side Branches: DCB-BIF

Caitlin E. Cox

October 28, 2024

News Conference News TCT 2024

EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis

Michael O'Riordan

October 28, 2024

News Daily News

Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced

Michael O'Riordan

September 20, 2024

News Conference News ESC 2024

SENIOR-RITA Offers Rare Insights Into Best Care for Older NSTEMI Patients

Michael O'Riordan

September 02, 2024

News Daily News

P2Y12 Inhibitor Pretreatment Worth Considering in STEMI When PCI Is Delayed

Yael L. Maxwell

June 20, 2024

News Daily News

RECOVER IV Impella Trial Halted in the Wake of DanGer Shock

Caitlin E. Cox

June 18, 2024

News Daily News

With ANOCA, Better to Test Coronary Function in Multiple Vessels

Caitlin E. Cox

May 29, 2024

News Daily News

Certain Periprocedural MIs Don’t Matter, New Data Allege

Michael O'Riordan

May 09, 2024

News Daily News

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

Michael O'Riordan

May 06, 2024

$Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC$

News Conference News ACC 2024

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Michael O'Riordan

April 08, 2024

News Daily News

M-TEER Outcomes at 1 Year Best at Hospitals With High Mitral Surgical Volumes

Michael O'Riordan

March 15, 2024

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

News Daily News

Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2

Michael O'Riordan

January 03, 2024

Advertisement

Immediate Angiography in OHCA Without STEMI Could Harm: TOMAHAWK and COACT

Top Coronary Artery Disease News in 2024

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

DCB Outdo Noncompliant Balloons in Simple Bifurcation Side Branches: DCB-BIF

EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis

Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced

SENIOR-RITA Offers Rare Insights Into Best Care for Older NSTEMI Patients

P2Y12 Inhibitor Pretreatment Worth Considering in STEMI When PCI Is Delayed

RECOVER IV Impella Trial Halted in the Wake of DanGer Shock

With ANOCA, Better to Test Coronary Function in Multiple Vessels

Certain Periprocedural MIs Don’t Matter, New Data Allege

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

M-TEER Outcomes at 1 Year Best at Hospitals With High Mitral Surgical Volumes

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content